Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adaptive licensing: creating a safe haven for discussions

This article was originally published in SRA

Executive Summary

The concept of adaptive licensing as a means of making innovative medicines available faster is generating much excitement, but some drug companies are worried about how this emerging approach might be implemented. Lynn Baird and Gigi Hirsch say their concerns can be overcome.

You may also be interested in...



China Price-Gouging Includes 'Huge' Sum For Antibiotic

A rare disclosure by China’s national health insurance payer shows how a major state-owned drug maker used its market-dominating position to dodge price-lowering schemes and increase drug prices more than 10-fold.

Accessing Unapproved Medical Devices – Comparing The Singapore And US Experiences

What are the special regulatory pathways that allow the use of unapproved devices? Asia Regulatory Professionals Association’s Rachel Lee and Helena Baric supply the answer, with reference to the systems used in the US and Singapore.

Health And Wellness Weekly Trademarks Review: 16 August

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest News
See All
UsernamePublicRestriction

Register

PS117496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel